Marzia Pennati - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	3
2006	3
2007	4
2008	2
2009	2
2010	2
2011	1
2012	5
2013	3
2014	2
2015	4
2016	7
2017	4
2018	3
2019	1
2020	1
2021	1
2024	0

1

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer.

Martini S, Zuco V, Tortoreto M, Percio S, Campi E, El Bezawy R, Doldi V, Landesman Y, Pennati M, Zaffaroni N. Martini S, et al. Among authors: pennati m. Pharmaceuticals (Basel). 2021 May 29;14(6):523. doi: 10.3390/ph14060523. Pharmaceuticals (Basel). 2021. PMID: 34072442 Free PMC article.

2

Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody.

Martini S, Figini M, Croce A, Frigerio B, Pennati M, Gianni AM, De Marco C, Daidone MG, Argueta C, Landesman Y, Zaffaroni N, Satta A. Martini S, et al. Among authors: pennati m. Cells. 2020 Oct 2;9(10):2231. doi: 10.3390/cells9102231. Cells. 2020. PMID: 33023194 Free PMC article.

3

Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.

Spinello A, Martini S, Berti F, Pennati M, Pavlin M, Sgrignani J, Grazioso G, Colombo G, Zaffaroni N, Magistrato A. Spinello A, et al. Among authors: pennati m. Eur J Med Chem. 2019 Apr 15;168:253-262. doi: 10.1016/j.ejmech.2019.02.045. Epub 2019 Feb 13. Eur J Med Chem. 2019. PMID: 30822713 Free article.

4

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy.

Bedini N, Cicchetti A, Palorini F, Magnani T, Zuco V, Pennati M, Campi E, Allavena P, Pesce S, Villa S, Avuzzi B, Morlino S, Visentin ME, Zaffaroni N, Rancati T, Valdagni R. Bedini N, et al. Among authors: pennati m. Dis Markers. 2018 Feb 25;2018:9128128. doi: 10.1155/2018/9128128. eCollection 2018. Dis Markers. 2018. PMID: 29682101 Free PMC article. Clinical Trial.

5

A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers.

Pavlin M, Spinello A, Pennati M, Zaffaroni N, Gobbi S, Bisi A, Colombo G, Magistrato A. Pavlin M, et al. Among authors: pennati m. Sci Rep. 2018 Jan 12;8(1):649. doi: 10.1038/s41598-017-17364-4. Sci Rep. 2018. PMID: 29330437 Free PMC article.

6

Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study.

Necchi A, Lo Vullo S, Raggi D, Perrone F, Giannatempo P, Calareso G, Togliardi E, Nicolai N, Piva L, Biasoni D, Catanzaro M, Torelli T, Stagni S, Colecchia M, Busico A, Pennati M, Zaffaroni N, Mariani L, Salvioni R. Necchi A, et al. Among authors: pennati m. Urol Oncol. 2018 Jan;36(1):8.e1-8.e8. doi: 10.1016/j.urolonc.2017.08.020. Epub 2017 Sep 12. Urol Oncol. 2018. PMID: 28911922 Clinical Trial.

7

Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents.

Beretta GL, Cassinelli G, Pennati M, Zuco V, Gatti L. Beretta GL, et al. Among authors: pennati m. Eur J Med Chem. 2017 Dec 15;142:271-289. doi: 10.1016/j.ejmech.2017.07.062. Epub 2017 Aug 3. Eur J Med Chem. 2017. PMID: 28851502 Review.

8

Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads.

D'Annessa I, Sattin S, Tao J, Pennati M, Sànchez-Martìn C, Moroni E, Rasola A, Zaffaroni N, Agard DA, Bernardi A, Colombo G. D'Annessa I, et al. Among authors: pennati m. Chemistry. 2017 Apr 19;23(22):5188-5192. doi: 10.1002/chem.201700169. Epub 2017 Mar 22. Chemistry. 2017. PMID: 28207175 Free PMC article.

9

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.

El Bezawy R, De Cesare M, Pennati M, Deraco M, Gandellini P, Zuco V, Zaffaroni N. El Bezawy R, et al. Among authors: pennati m. J Hematol Oncol. 2017 Jan 18;10(1):19. doi: 10.1186/s13045-016-0387-6. J Hematol Oncol. 2017. PMID: 28100259 Free PMC article.

10

Strategies to Strike Survival Networks in Cancer.

Pennati M, Cimino-Reale G, Gatti L, Cassinelli G. Pennati M, et al. Crit Rev Oncog. 2016;21(3-4):269-308. doi: 10.1615/CritRevOncog.2016016966. Crit Rev Oncog. 2016. PMID: 27915976 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

48 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year